R

Redhill Biopharma Ltd
D

RDHL

1.86000
USD
-0.59
(-24.08%)
مغلق
حجم التداول
1,374
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
4,269,342
أصول ذات صلة
A
AKRO
-2.280
(-4.19%)
52.090 USD
A
ALLO
0.01000
(0.81%)
1.24500 USD
D
DRRX
0.02770
(5.41%)
0.53970 USD
G
GNFT
0.22000
(5.88%)
3.96000 USD
I
IMUX
0.04010
(4.31%)
0.97050 USD
K
KALA
-0.19000
(-3.19%)
5.77000 USD
R
RCKT
-0.30500
(-9.13%)
3.03500 USD
S
SNGX
-0.02500
(-1.80%)
1.36500 USD
المزيد
الأخبار المقالات

العنوان: Redhill Biopharma Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-relatedproducts in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.